NEWS

 
PRESS RELEASE
Vivlion licenses CRISPR/Cas9 patent portfolio from Broad Institute
PRESS RELEASE
Vivlion GmbH signs worldwide license agreement with ERS Genomics for CRISPR/Cas9 patent portfolio
HIGHLIGHTED IN THE SPINOFF PRIZE
Vivlion is selected as "one to watch" in the new Spinoff Prize competition launched by Nature and Merck KGaA
NEWS & PRESS
GIT Laborportal features 3Cs technology
FEATURED CITATION
Publication of 3Cs technology in Elife: 
Wegner M et al., doi: 10.7554/eLife.42549
NEWS & PRESS
Goethe University Frankfurt am Main announces spin-off of Vivlion GmbH
FEATURED PRESENTATION
Vivlion CSO Manuel Kaulich giving a LabRoots presentation

© 2019 by Vivlion GmbH                                                                                                                           
Geschäftsführer: Prof. Dr. Ivan Dikic • Dr. Manuel Kaulich • Dr. Kerstin Koch            
IMPRINT    PRIVACY    T&C

CRISPR gRNA library libraries 3Cs CRISPR/Cas Vivlion GmbH pooled arrayed CRISPR/Cas reagents screens validated products single multiplex multiplexing fixed-pair predefined combinations combinatorial screening